HealthMore in Health →
Nature Medicine Highlight Points to Early Promise for Stem-Cell-Aided Prenatal Spina Bifida Surgery
A Nature Medicine research highlight says a phase 1 study found placenta-derived stem cell therapy used during in utero myelomeningocele repair showed promise in an early safety assessment.
Key Takeaways
- A Nature Medicine highlight describes a phase 1 safety study in fetal myelomeningocele repair.
- The approach uses placenta-derived stem cells during prenatal surgery.
DE
DT Editorial AI··via nature.com